BLACK FRIDAY DEALS: Click Here
Johnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of Stroke

Johnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of Stroke

Posted by · 5284 views · Translate

Johnson & Johnson, in collaboration with Apple, has announced that enrollment for a new Heartline Study is now open. The study will explore if a new Heartline app for iPhone and the Apple Watch can reduce the risk of stroke with earlier detection of atrial fibrillation (AFib).

To enroll in the Heartline Study, individuals must be age 65 or older, a U.S. resident, have Original (traditional) Medicare, own an iPhone 6s or a later model, and agree to provide access to their Medicare claims data.

"Heartline is a study that has the potential to fundamentally change our understanding of how digital health tools, like the ECG app and irregular rhythm notification feature on Apple Watch, could lead to earlier detection of AFib, helping patients understand and directly engage in their heart health, prompting potentially life-saving conversations with their doctors, and improving health outcomes," notes Dr. C. Michael Gibson, Co-Chair of the Heartline Executive Committee and Professor of Medicine, Harvard Medical School and CEO, Baim Institute.

Despite the fact that AFib is a leading cause of stroke, people often do not experience symptoms, making it difficult to diagnose. More than 33 million people worldwide and up to six million Americans live with AFib. Up to 30% don't even know they have it until a serious cardiovascular event, such as a stroke, occurs. According to the U.S. Centers for Disease Control and Prevention, AFib, the most common sustained cardiac arrhythmia, results in 158,000 deaths and 454,000 hospitalizations each year.

"As we look to tackle some of the greatest health care challenges, we must bring the best minds and capabilities to the table," said Paul Burton, M.D., Ph.D., FACC, Vice President, Medical Affairs, Internal Medicine, Janssen Scientific Affairs, LLC, a Janssen Pharmaceutical Company of Johnson & Johnson. "Through this important collaboration with Apple, we are pioneering new models that we hope can break down some of the most common barriers to participation in clinical studies. Our work continues to develop and deliver solutions for those impacted by AFib in the areas of detection, treatment and care, through novel approaches, so that we can potentially improve their lives today and well into the future."

To learn more about the study or enroll, visit the link below!

Read More


Johnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of StrokeJohnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of Stroke

Johnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of StrokeJohnson & Johnson Launches 'Heartline Study' to Explore if iPhone and Apple Watch Can Reduce Risk of Stroke

Recent